SCHEMBL13336390

SCHEMBL13336390

CC(C)(C)OC(=O)N[C@@H]1COCCCCCCCC[C@H](B2OC3CC4CC(C3O2)C4(C)C)NC(=O)[C@@H]2C[C@@H](OC(=O)N3Cc4ccccc4C3)CN2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13363193 1.00 — —
SCHEMBL8188558 1.00 — —
SCHEMBL13363332 0.86 FAP (0.36) —
SCHEMBL8201674 0.86 FAP (0.36) —
SCHEMBL13336393 0.86 FAP (0.36) —
SCHEMBL8193266 0.84 PPIA (0.34) —
SCHEMBL13284066 0.82 REN (0.31) —
SCHEMBL13336392 0.81 NAMPT (0.33) —
SCHEMBL8180607 0.81 NAMPT (0.33) —
SCHEMBL13573876 0.80 PREP (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120716-A1 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR PHENOMIX CORPORATION (US) 2010-05-13 — — US disclosed
Send feedback